Moderna strikes licensing deal with Generation Bio for genetic medicines

Generation Bio

23/03/2023 11:12

March 23 (Reuters) - Moderna Inc  MRNA.O  on Thursday
said it had entered into a licensing deal and would make a $36
million equity investment in Generation Bio Co  GBIO.O  to
develop genetic medicines. 

 (Reporting by Mariam Sunny in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Mariam.ESunny@thomsonreuters.com;))